Reframing Alzheimer’s Drug Development: Clinical Signals, Regulatory Review, and the Path Forward for ANAVEX®2-73

Thursday, January 8, 2026

11:00 AM – 12:00 PM ET

Jason Kolbert

Head of Research
D. Boral Capital

Christopher U. Missling, PhD, MS, MBA

President and CEO
Anavex

Watch Webinar